A clinical trial to study the effect of Bharangyadi Kashaya in the dose of 50ml twice a day in comparison with Nidhigdikadi Kashaya in the dose of 50ml twice a day in the management of Bronchial Asthma in adults aged 18-60 years for a period of 30 days.

To study the efficacy of Bharangyadi Kashaya in comparison with Nidhigdikadi Kashaya in Tamaka Swasa, Bronchial Asthma: A controlled randomized clinical study - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080901

Enrollment

Registered

2025-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma Health Condition 2: J453- Mild persistent asthma Health Condition 3: J454- Moderate persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects fulfilling the diagnostic criteria of Tamaka Swasa. 2.Subjects having peak expiratory flow rate greater than 50 percentage of predicted value of Peak Expiratory Flow Rate chart. 3.Subjects within the age group of 18 to 60 years. 4.Chronicity less than or equal to 10 years.

Exclusion criteria

Exclusion criteria: 1.Acute condition of Bronchial Asthma, Status asthmaticus. 2.Subjects suffering from associated diseases like Tuberculosis, pneumonia, Cardiac diseases, Uncontrolled Diabetes mellitus, Uncontrolled Hypertension. 3.Subjects having peak expiratory flow rate less than 50 percentage of predicted value of Peak Expiratory Flow Rate chart. 4.Subjects who are on corticosteroids. 5.Chronicity of more than 10 years. 6.Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Improvement in peak Expiratory Flow Rate and Absolute Eosinophil count in patients diagnosed with Tamaka Swasa. Timepoint: 0th day (Baseline), 15th day, 30th day and 45th day	—

Secondary

Measure	Time frame
Improvements in reduction of signs and symptoms in patients diagnosed with Tamaka Swasa based on Asthma Control QuestionnaireTimepoint: 0th day (Baseline), 15th day, 30th day and 45th day	—

Countries

India

Contacts

Public ContactDr B Sanjuktha Shree

Shri Dharmasthala Manjunatheshwara Institute

drsharmamysr@gmail.com9964022654

Outcome results